1321.7 Hemorrhage

Bleeding and Clotting Disorders


Condition or Disease: Hemorrhage

Study Type: Interventional (Clinical Trial)

Status: Open for enrollment

Study Title: Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary prevention of venous thromboembolism.

Principal I investigator: Alan Ikeda, MD

More Info: //clinicaltrials.gov/ct2/show/NCT02815670

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News


Cure 4 The Kids Foundation Adds Dr. Suraj Pratap To Its Team of Exceptional Providers

Cure 4 The Kids Foundation (C4K) is pleased to announce the addition of Dr. Suraj Pratap, M.D. to their team of healthcare providers. Dr. Pratap brings with him a wealth of experience, having previously practiced general pediatrics in Las Vegas. He recently obtained his board-certification in pediatric hematology oncology, which will provide additional resources and expertise to C4K’s existing team of seven providers. Fluent in both English and Hindi, Dr. Pratap is now seeing C4K patients.